Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers

Overview of attention for article published in Genetics in Medicine, January 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

blogs: 1 blog
twitter: 27 X users

facebook: 3 Facebook pages

Citations

dimensions_citation: 77 Dimensions

Readers on

mendeley: 99 Mendeley

Summary Blogs X Facebook Dimensions citations

So far, Dimensions has found 77 publications that cite this research output.

77

The most recent citing publications are shown below. View all 77 publications that cite this research output on Dimensions.

Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer

Article in PLOS ONE (April 2024)

Chest Wall Perforator Flap Partial Breast Reconstruction: A Retrospective Analysis of Surgical, Cosmetic and Survival Outcome

Article in Ecancermedicalscience (March 2024)

Germline mutations of 4567 patients with hereditary breast-ovarian cancer spectrum in Thailand

Article in npj Genomic Medicine (February 2024)